Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Enhancement of radiopharmaceutical excretion by chemical interventions

Conference ·
OSTI ID:6620601
The goal was to find methods of decreasing the radiation dose after radionuclide studies, by giving a compound that will increase the rate of excretion of the radionuclide. Sprague - 1 Dawley rats were given Tc-99m pertechnetate, Ga-67 citrate or Tl-201 chloride intravenously followed at intervals of 1 to 24 hours by one of the following compounds: desferroxamine (DFO), 2,3-dimercapto-1-propanol (BAL), triethylene tetraamine hexaacetic acid (TETHA), stannous tartarate, bleomycin (BLEO), 2,3-dimercaptosuccinic acid (DMSA), diethylene-triaminepentaacetic acid (DTPA), DTPA+SnCl.2H/sub 2/O, dihydroxybenzoic acid (DHB), and ferric-cyanoferrate (IT)(Prussian blue, PB). All the agents except PB are chelators. Some of these agents enhance excretion through the urinary tract (DFO), while most are excreted through the bile. PB was shown to increase Cs excrection through the G.I. tract. (ACR)
Research Organization:
Brookhaven National Lab., Upton, NY (USA); State Univ. of New York, Stony Brook (USA)
DOE Contract Number:
AC02-76CH00016
OSTI ID:
6620601
Report Number(s):
BNL-30628; CONF-820804-4; ON: DE83003217
Country of Publication:
United States
Language:
English

Similar Records

Alteration of tissue disposition of cadmium by chelating agents. [Mice; rats]
Journal Article · Wed Feb 29 23:00:00 EST 1984 · Environ. Health Perspect.; (United States) · OSTI ID:5762371

Chelation in metal intoxication. XIII. Polyaminocarboxylic acids as chelators in lead poisoning
Journal Article · Fri Dec 31 23:00:00 EST 1982 · Bull. Environ. Contam. Toxicol.; (United States) · OSTI ID:6165412

Influence of 2,3-dimercaptosuccinic acid on gastrointestinal lead absorption and whole-body lead retention
Journal Article · Tue Feb 28 23:00:00 EST 1989 · Toxicology and Applied Pharmacology; (USA) · OSTI ID:6982921